Found: 13
Select item for more details and to access through your institution.
Characterization of the SARS-CoV-2 antibody landscape in Norway in the late summer of 2022: high seroprevalence in all age groups with patterns of primary Omicron infection in children and hybrid immunity in adults.
- Published in:
- BMC Infectious Diseases, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12879-024-09670-w
- By:
- Publication type:
- Article
The Specificity of Targeted Vaccines for APC Surface Molecules Influences the Immune Response Phenotype.
- Published in:
- PLoS ONE, 2013, v. 8, n. 11, p. 1, doi. 10.1371/journal.pone.0080008
- By:
- Publication type:
- Article
Household Transmission of SARS-CoV-2: A Prospective Longitudinal Study Showing Higher Viral Load and Increased Transmissibility of the Alpha Variant Compared to Previous Strains.
- Published in:
- Microorganisms, 2021, v. 9, n. 11, p. 2371, doi. 10.3390/microorganisms9112371
- By:
- Publication type:
- Article
Recombinant antibodies for delivery of antigen: a single loop between {beta}-strands in the constant region can accommodate long, complex and tandem T cell epitopes.
- Published in:
- International Immunology, 2008, v. 20, n. 3, p. 295, doi. 10.1093/intimm/dxm141
- By:
- Publication type:
- Article
Endocytic pathways regulate Toll-like receptor 4 signaling and link innate and adaptive immunity.
- Published in:
- EMBO Journal, 2006, v. 25, n. 4, p. 683, doi. 10.1038/sj.emboj.7600991
- By:
- Publication type:
- Article
Epitope specific T-cell responses against influenza A in a healthy population.
- Published in:
- Immunology, 2016, v. 147, n. 2, p. 165, doi. 10.1111/imm.12548
- By:
- Publication type:
- Article
Immune responses of a meningococcal A + W outer membrane vesicle (OMV) vaccine with and without aluminium hydroxide adjuvant in two different mouse strains.
- Published in:
- APMIS, 2016, v. 124, n. 11, p. 996, doi. 10.1111/apm.12589
- By:
- Publication type:
- Article
Prevalence of antibodies against SARS‐CoV‐2 in the Norwegian population, August 2021.
- Published in:
- Influenza & Other Respiratory Viruses, 2022, v. 16, n. 6, p. 1004, doi. 10.1111/irv.13024
- By:
- Publication type:
- Article
Trends in seroprevalence of SARS‐CoV‐2 and infection fatality rate in the Norwegian population through the first year of the COVID‐19 pandemic.
- Published in:
- Influenza & Other Respiratory Viruses, 2022, v. 16, n. 2, p. 204, doi. 10.1111/irv.12932
- By:
- Publication type:
- Article
Detection of anti‐NS1 antibodies after pandemic influenza exposure: Evaluation of a serological method for distinguishing H1N1pdm09 infected from vaccinated cases.
- Published in:
- Influenza & Other Respiratory Viruses, 2020, v. 14, n. 3, p. 294, doi. 10.1111/irv.12712
- By:
- Publication type:
- Article
Antibody levels in a cohort of pregnant women after the 2009 influenza A(H1N1) pandemic: Waning and association with self‐reported severity and duration of illness.
- Published in:
- Influenza & Other Respiratory Viruses, 2019, v. 13, n. 2, p. 191, doi. 10.1111/irv.12623
- By:
- Publication type:
- Article
Risk of pregnancy complications and adverse birth outcomes after maternal A(H1N1)pdm09 influenza: a Norwegian population-based cohort study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Immune Responses in Acute and Convalescent Patients with Mild, Moderate and Severe Disease during the 2009 Influenza Pandemic in Norway.
- Published in:
- PLoS ONE, 2015, v. 10, n. 11, p. 1, doi. 10.1371/journal.pone.0143281
- By:
- Publication type:
- Article